No difference in prevalence of H63D between AD patients and controls (42.6% vs. 34.5%; p-value not reported). No difference in prevalence of C282Y between AD patients and controls (3.7% vs. 3.6%; p-value not reported). Neither became significant when stratifying ApoE status or TF C2 presence (p-values not reported). The gene discussed is APOE; the disease is Alzheimer disease.